Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease
Author:
Open Access
- 1 February 2011
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 44 (2) , 84-90
Abstract
Infection with the protozoan parasite Trypanosoma cruzi leads to Chagas disease, which affects millions of people in Latin America. Infection with T. cruzi cannot be eliminated by the immune system. A better understanding of immune evasion mechanisms is required in order to develop more effective vaccines. During the acute phase, parasites replicate extensively and release immunomodulatory molecules that delay parasite-specific responses mediated by T cells. This immune evasion allows the parasite to spread in the host. In the chronic phase, parasite evasion relies on its replication strategy of hijacking the TGF-β signaling pathway involved in inflammation and tissue regeneration. In this article, the mechanisms of immune evasion described for T. cruzi are reviewed.Keywords
This publication has 61 references indexed in Scilit:
- Coinfection with Different Trypanosoma cruzi Strains Interferes with the Host Immune Response to InfectionPLOS Neglected Tropical Diseases, 2010
- Impaired Innate Immunity in Tlr4−/− Mice but Preserved CD8+ T Cell Responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-Deficient MicePLOS Pathogens, 2010
- Trypanosoma cruzi Subverts Host Cell Sialylation and May Compromise Antigen-specific CD8+ T Cell ResponsesJournal of Biological Chemistry, 2010
- Chagas diseaseThe Lancet, 2010
- Regulation of Adaptive Immunity by the Innate Immune SystemScience, 2010
- Genomic organization and expression profile of the mucin-associated surface protein (masp) family of the human pathogen Trypanosoma cruziNucleic Acids Research, 2009
- Trypanosoma cruziInduces Regulatory Dendritic Cells In VitroInfection and Immunity, 2008
- Contextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10Immunity, 2008
- CD4 cells can be more efficient at tumor rejection than CD8 cellsBlood, 2007
- CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase EpitopesPLOS Pathogens, 2006